192 related articles for article (PubMed ID: 29561464)
1. Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
Hu Y; Liu Y; Shi H
Medicine (Baltimore); 2018 Mar; 97(12):e9939. PubMed ID: 29561464
[TBL] [Abstract][Full Text] [Related]
2. Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT.
Liu M; Zhou J; Zhu W; Huo L; Cheng W
Clin Nucl Med; 2023 Nov; 48(11):985-986. PubMed ID: 37703486
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT of Internal Mammary Lymph Node Hepatocellular Carcinoma Metastases.
Senthil R; Ramesh H; Visakh R A; Pratap T; Mahadevan P
Clin Nucl Med; 2018 Dec; 43(12):e482-e483. PubMed ID: 30358626
[TBL] [Abstract][Full Text] [Related]
4. Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Dong A; Dong H; Zuo C
Clin Nucl Med; 2014 Jan; 39(1):e69-72. PubMed ID: 23486333
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
Zhang W; Fang C; Liu H; Chen Y
Clin Nucl Med; 2019 Feb; 44(2):130-132. PubMed ID: 30562190
[TBL] [Abstract][Full Text] [Related]
6. Colonic Castleman Disease on FDG PET/CT.
Li F; Xiao L; Cai H; Li L
Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
[TBL] [Abstract][Full Text] [Related]
7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
8. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
Fu Z; Liu M; Chen X; Yang X; Li Q
Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
[TBL] [Abstract][Full Text] [Related]
11. Solitary Accessory Spleen-Like Metastasis Coexisted With Splenic Infarction Reveled on 18F-FDG PET/CT in a Hepatocellular Carcinoma Patient.
Shao F; Xie P
Clin Nucl Med; 2023 Mar; 48(3):269-270. PubMed ID: 36723887
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Wang XL; Li H; Wang QS; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using
Wang ZF; Fan XX; Xu M; Chen MJ; Zhao ZW; Zhou JD; Tu JF; Song JJ; Hu XH; Lu CY; Wu FZ; Zhang DK; Chen L; Liu L; Ying XH; Xu XF; Ji JS
Tumour Biol; 2017 May; 39(5):1010428317701656. PubMed ID: 28475013
[TBL] [Abstract][Full Text] [Related]
15. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
16. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection.
Morio K; Kawaoka T; Aikata H; Namba M; Uchikawa S; Kodama K; Ohya K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Nakamura Y; Akagi M; Awai K; Kobayashi T; Ohdan H; Chayama K
Eur J Radiol; 2020 Mar; 124():108828. PubMed ID: 31955034
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Metastasis From Hepatocellular Carcinoma Visualized by 18F-FDG PET/CT Imaging.
Yin H; Luo R; Xiu Y; Hu Y; Shi H
Clin Nucl Med; 2018 Dec; 43(12):e455-e457. PubMed ID: 30247212
[TBL] [Abstract][Full Text] [Related]
19. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
Wang P; Hou G; Li F; Cheng X
Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
[TBL] [Abstract][Full Text] [Related]
20. Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
Clin Nucl Med; 2015 Jun; 40(6):e325-7. PubMed ID: 25546205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
